40
Participants
Start Date
June 1, 2022
Primary Completion Date
November 1, 2023
Study Completion Date
November 1, 2023
Melatonin
Participants will be randomized into two groups (Group A and Group B). Group A will initially be treated with 3 mg melatonin supplements over a 4-week period while Group B will initially receive placebo supplements over a 4-week period. After a 4-week washout period, Group A will receive placebo supplements while Group B will receive 3 mg melatonin supplements.
Placebo
Placebo
BC Cancer Research Center, Vancouver
University of British Columbia
OTHER